222nd ENMC International Workshop:: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1-2 July 2016
Neuromuscul Disord
.
2018 May;28(5):463-469.
doi: 10.1016/j.nmd.2018.02.003.
Epub 2018 Feb 12.
Authors
Libby Wood
1
,
Guillaume Bassez
2
,
Baziel van Engelen
3
,
Hanns Lochmüller
4
,
Benedikt Schoser
5
;
222nd ENMC workshop participants
Collaborators
222nd ENMC workshop participants
:
Antonio Atalaia
6
,
Pavel Balabanov
7
,
Guillaume Bassez
8
,
Matthias Boentert
9
,
Jeanette Charlton
10
,
Baziel van Engelen
11
,
Cynthia Gagnon
12
,
Alain Geille
13
,
Chad Heatwole
14
,
Arend Heerschap
11
,
Marie Kierkegaard
15
,
Cornelia Kornblum
16
,
Christopher Lindberg
17
,
Hanns Lochmüller
18
,
Giovanni Meola
19
,
Laurence Mignon
20
,
Darren Monckton
21
,
John Porter
22
,
Valeria Sansone
19
,
Benedikt Schoser
23
,
Vidosava Stojanović
24
,
Rachel Thompson
6
,
Shaun Treweek
25
,
John Vissing
26
,
Libby Wood
6
Affiliations
1
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, UK. Electronic address:
[email protected]
.
2
Neuromuscular Reference Center, Henri Mondor, L'assitance Publique - Hopitaux de Paris, France.
3
Department of Neurology, Radboud University Medical Centre, Netherlands.
4
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, UK.
5
Friedrich-Baur-Institute, Department of Neurology University Clinics Ludwig-Maximilians-University of Munich, Germany.
6
Newcastle, UK.
7
European Medicines Agency, UK.
8
Paris, France.
9
Münster, Germany.
10
Patient and family representative, UK.
11
Nijmegen, The Netherlands.
12
Quebec, Canada.
13
Patient and family representative, France.
14
Rochester, USA.
15
Stockholm, Sweden.
16
Bonn, Germany.
17
Gothenburg, Sweden.
18
Newcastle University, UK.
19
Milan, Italy.
20
IONIS Pharmaceuticals, USA.
21
Glasgow, UK.
22
Myotonic Dystrophy Foundation, USA.
23
Munich, Germany.
24
Belgrade, Serbia.
25
Aberdeen, UK.
26
Copenhagen, Denmark.
PMID:
29550152
DOI:
10.1016/j.nmd.2018.02.003
No abstract available
Publication types
Congress
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Myotonic Dystrophy / therapy*
Netherlands